[1] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management,prevention of chronic obstructive pulmonary disease:2026 report[EB/OL].(2025-11- 11)[2026-07-05]. https://goldcopd.org/2026-gold-report-and-pocket-guide/. [2] Wang Z F, Lin J F, Liang L N, et al.Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021[J]. Respiratory Research, 2025, 26(1): 2. [3] Boers E, Allen A, Barrett M, et al.Forecasting the global economic and health burden of COPD from 2025 through 2050[J]. Chest, 2025, 168(4): 880-889. [4] Lee H W.Pharmacologic Therapies for preventing chronic obstructive pulmonary disease exacerbations: a comprehensive review[J]. Tuberculosis and Respiratory Diseases, 2025, 88(2): 216-227. [5] Yang M, Du Y, Chen H, et al.Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials[J]. International Immunopharmacology, 2019, 77: 105950. [6] Zeng S, Bai H, Zou M.Effects of roflumilast on patients with chronic obstructive pulmonary disease treated with inhaled corticosteroid/long-acting β2 agonist: a meta-analysis[J]. Computational and Mathematical Methods in Medicine, 2022, 2022: 8101099. [7] Albert R K, Connett J, Bailey W C, et al.Azithromycin for prevention of exacerbations of COPD[J]. The New England Journal of Medicine, 2011, 365(8): 689-698. [8] Buendía J A, Manrique Acevedo L F, Celis Preciado C.“beyond triple therapy: is dupilumab a cost-effective option for copd with type 2 inflammation?”[J]. Respiratory Medicine, 2025, 247: 108254. [9] Pharmacopoeia Committee of the Ministry of Health of the PRC. Drug Standards of the Ministry of Health of the People’s Republic of China: Mongolian Medicine Volume (中华人民共和国卫生部药品标准:蒙药分册)[S]. Hohhot: Inner Mongolia Science and Technology Press, 1998. [10] Xi Lintuya, Bai Luming, Li Shuming, et al.Research progress on chemical constituents and pharmacological effects of Mongolian medicine Gentiana macrophylla[J]. Journal of Medicine & Pharmacy of Chinese Minorities(中国民族医药杂志), 2023, 29(3): 57-60. [11] Li Y, Zhao Y, Tan X, et al.Isoorientin inhibits inflammation in macrophages and endotoxemia mice by regulating glycogen synthase kinase 3β[J]. Mediators of Inflammation, 2020, 2020: 8704146. [12] Tan X Q, Cao M D, Zhao Y J, et al.Neuroprotection of isoorientin against microglia activation induced by lipopolysaccharide via regulating GSK3β, NF-κB and Nrf2/HO-1 pathways[J]. Immunophar-macology and Immunotoxicology, 2024, 46(6): 741-750. [13] Wang Z Z, Yang L Z, Feng Y, et al.Isoorientin alleviates DSS-treated acute colitis in mice by regulating intestinal epithelial P-Glyco-protein (P-gp) expression[J]. DNA and Cell Biology, 2024, 43(10): 520-536. [14] Zhang L, Zhu X Z, Badamjav R, et al.Isoorientin protects lipopolysaccharide-induced acute lung injury in mice via modulating Keap1/Nrf2-HO-1 and NLRP3 inflammasome pathways[J]. European Journal of Pharmacology, 2022, 917: 174748. [15] Hu M, Yang J L, Xu Y.Isoorientin suppresses sepsis-induced acute lung injury in mice by activating an EPCR-dependent JAK2/STAT3 pathway[J]. Journal of Molecular Histology, 2022, 53(1): 97-109. [16] Liang S, Zhao Y, Chen G, et al.Isoorientin ameliorates OVA-induced asthma in a murine model of asthma[J]. Experimental Biology and Medicine (Maywood, NJ), 2022, 247(16): 1479-1488. [17] Zhang Wenxue, Wang Ning, Guo Qi, et al.Active consituents of Mongolian medicine Gentiana dahurica Fisch. flower ameliorate chronic obstructive pulmonary disease in mice through the NF-κB signaling pathway[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2026, 23(1): 34-41. [18] Wang N, Zhang W X, Li J, et al.Bioactive components of Mongolian medicinal Gentiana dahurica Fisch. flowers inhibit the NF-κB signaling pathway and ameliorate chronic obstructive pulmonary disease[J]. Journal of Ethnopharmacology, 2026, 371: 122068. [19] Wang Ning, Wang Minjie, Li Jun, et al.HPLC-Q-Exactive-MS was used to analyze the chemical components,serum and lung tissue migration components of Mongolian medicine[J]. Journal of Medicine & Pharmacy of Chinese Minorities(中国民族医药杂志), 2025, 31(5): 29-36. [20] Zhou F X, Cai J W, Chen L, et al.ADRA2A contributes to airway inflammation and apoptosis in asthma through the ERK signaling in vitro and in vivo[J]. Journal of Inflammation (London, England), 2025, 22(1): 55. [21] Gonçalves P B, Romeiro N C.Multi-target natural products as alternatives against oxidative stress in chronic obstructive pulmonary disease (COPD)[J]. European Journal of Medicinal Chemistry, 2019, 163: 911-931. [22] Fei Xinru, Yang Guixian, Liu Junnan, et al.Therapeutic effects of natural products on animal models of chronic obstructive pulmonary disease[J]. Journal of Central South University (Medical Sciences)(中南大学学报医学版), 2025, 50(6): 1067-1079. [23] Qi Y, Yan Y, Tang D, et al.Inflammatory and immune mechanisms in COPD: current status and therapeutic prospects[J]. Journal of Inflammation Research, 2024, 17: 6603-6618. [24] Zhu Shunjuan, Wang Xiaopeng, Lu Jianlong, et al.Comparative study on the content of index components in flowers and roots of Gentiana dahurica[J]. Journal of Traditional Chinese Veterinary Medicine(中兽医医药杂志), 2023, 42(4): 20-24. [25] Peng Meichen, Ai Xiaohui.Research progress in chemical constituents, pharmacological effects and clinical application of the flowers of Gentianae Macrophylla[J]. Central South Pharmacy(中南药学), 2021, 19(6): 1243-1249. [26] Zeng S, Zhang Y, Li S, et al.From metabolic alterations to chronic inflammation: mechanisms and immunoregulation of metabolic reprogramming in COPD[J]. Frontiers in Immunology, 2025, 16: 1698832. [27] Wang T, Dong Y, Fang L, et al.Patterns and underlying mechanisms of airway epithelial cell death in COPD[J]. COPD: Journal of Chronic Obstructive Pulmonary Disease, 2025, 22(1): 2542153. [28] Chen J, Dai L, Wang T, et al.The elevated CXCL5 levels in circulation are associated with lung function decline in COPD patients and cigarette smoking-induced mouse model of COPD[J]. Annals of Medicine, 2019, 51(5-6): 314-329. [29] Yu Y, Yang A, He X, et al.Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway[J]. Journal of Inflammation (London, England), 2023, 20(1): 36. |